UCLA researchers apply critical race theory to public health care to create the "public health critical race praxis" for utilization across patient studies.
Researchers followed 180 patients treated with phrenic nerve reconstruction. 89% of these patients reported an overall improvement in breathing function.
The new medication targets a protein called apolipoprotein C-III. By neutralizing this protein, it effectively speeds up the breakdown of triglycerides.